Directory
>
Zhiqian Lucy Liu
Zhiqian Lucy Liu
VP Head of Protein Science & Bioanalytics | Alloy Therapeutics, Inc.
Cambridge, Massachusetts, United States
Zhiqian Lucy Liu
Summary
Zhiqian Lucy Liu is a highly accomplished professional in the field of protein science and bioanalytics, currently serving as the Vice President at Alloy Therapeutics. With a strong academic background, including a Ph.D. in Biochemistry from McGill University, she has dedicated her career to advancing drug discovery and biochemistry. Her extensive experience spans various leadership roles in biotechnology companies, where she has successfully led teams in the development of novel therapeutic proteins and assays. Lucy's expertise encompasses a wide range of techniques including flow cytometry, ELISA, and Western blotting, making her a valuable asset in the life sciences sector. Her research has been published in reputable journals, highlighting her contributions to cancer biology and therapeutic advancements. Lucy is not only a leader in her field but also a mentor, fostering the next generation of scientists. Her passion for innovation and commitment to improving patient outcomes drives her professional endeavors.
Zhiqian Lucy Liu
Work Experience
VP Head of Protein Science & Bioanalytics at
Alloy Therapeutics, Inc.
August 2024 - Present
Senior Director, Global Head of Bioanalytics at
Alloy Therapeutics, Inc.
June 2021 - August 2024
Director, Head of Protein Analytics at
Alloy Therapeutics, Inc.
April 2020 - July 2021
Director, High-Throughput Characterization at
Compass Therapeutics Inc.
February 2020 - April 2020
Associate Director at
Compass Therapeutics Inc.
September 2018 - February 2020
Principal Scientist at
Compass Therapeutics Inc.
October 2016 - September 2018
Scientist II, Project Leader at
Biogen
June 2014 - October 2016
Scientist I, Project Leader at
Biogen
January 2011 - June 2014
Post-Doctoral Scientist, In Vitro Methods, Antibody Technologies at
EMD Serono, Inc.
January 2010 - January 2011
Post-Doc Fellow at
Dana-Farber Cancer Institute
January 2006 - January 2010
Zhiqian Lucy Liu
Education
McGill University, Ph.D
January 2000 - January 2006
Frequently Asked Questions about Zhiqian Lucy Liu
What is Zhiqian Lucy Liu email address?
Zhiqian Lucy Liu's primary email address is ***********@alloytx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Zhiqian Lucy Liu work for?
Zhiqian Lucy Liu is a VP Head of Protein Science & Bioanalytics at Alloy Therapeutics, Inc., a company specializing in Commercial physical research.
Where Zhiqian Lucy Liu graduated from?
Zhiqian Lucy Liu holds a degree in Biochemistry from McGill University.
How can I directly contact Zhiqian Lucy Liu?
To contact Zhiqian Lucy Liu directly, you can use the email address ***********@alloytx.com. Complete contact information is available upon registration with Muraena.
Who is Zhiqian Lucy Liu?
Zhiqian Lucy Liu is a highly accomplished professional in the field of protein science and bioanalytics, currently serving as the Vice President at Alloy Therapeutics. With a strong academic background, including a Ph.D. in Biochemistry from McGill University, she has dedicated her career to advancing drug discovery and biochemistry. Her extensive experience spans various leadership roles in biotechnology companies, where she has successfully led teams in the development of novel therapeutic proteins and assays. Lucy's expertise encompasses a wide range of techniques including flow cytometry, ELISA, and Western blotting, making her a valuable asset in the life sciences sector. Her research has been published in reputable journals, highlighting her contributions to cancer biology and therapeutic advancements. Lucy is not only a leader in her field but also a mentor, fostering the next generation of scientists. Her passion for innovation and commitment to improving patient outcomes drives her professional endeavors.
Zhiqian`s contact details
***********@alloytx.com
Colleagues
General Partner
CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery
Vice President of Daedamab Business Development
Harvard Business Review Advisory Council Member
Senior Vice President Therapeutic Discovery Strategies